CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 16 enrolled
Drug / intervention
Aminophylline +2 moredrug
Likely dose
Aminophylline 500mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01587027
NCT01587027Phase 1Completed
CompareCT.gov

The Safety Evaluation of Aminophylline and Methazolamide When Administered Orally Alone and in Combination to Healthy Volunteers

Poudre Valley Health System·interventional·Posted Apr 27, 2012·Updated Feb 10, 2017

In Brief

A Phase 1 clinical trial evaluating Aminophylline, Methazolamide, and 1 other intervention for Mountain Sickness. Completed, enrolled 16 participants across 1 site.

Detailed Summary

This safety study is the first in a series of studies testing the application of the combination of aminophylline and methazolamide.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMountain Sickness
CountriesUnited States
CollaboratorsDefense Advanced Research Projects Agency, University of Colorado, Denver

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedApr 27, 2012
Enrollment StartDec 1, 2011
Primary CompletionFeb 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 14.2 years ago

Interventions

Aminophyllinedrug

Aminophylline dosage form-tablet dosage-500mg

Methazolamidedrug

Methazolamide dosage form-tablet dosage-250mg

Aminophylline and Methazolamidedrug

Aminophylline 500mg orally and Methazolamide 250mg orally